Musculoskeletal Manifestations Of Lupus
Published on: October 31, 2024
Musculoskeletal Manifestations Of Lupus

Introduction

Systemic lupus erythematosus (SLE), shortly known as lupus, is a chronic autoimmune multisystemic disease that affects many systems of the body causing a wide range of symptoms involving the skin, joints, kidneys, blood cells, and nervous system, ranging from mild to severe life-threatening symptoms. Although some drugs can cause lupus-like symptoms, the term SLE is often called for the type of lupus that is autoimmune and that affects various body organs.

For many years, SLE patients died due to associated complications after being diagnosed, where they were considered as having terminal disease. However, nowadays, due to recent advances in medicine, patients with SLE are being diagnosed early and are being offered early treatment modalities which helped in increasing their life span in addition to decreasing the progression of the disease.

Roughly 90% of cases of SLE occur in women. Although it can affect different ages, women between the ages of 15 and 50 years old are more likely to have the disease. People of African, Caribbean, or Asian descent seem to have the syndrome more frequently than individuals of white European descent. 1

Although the exact origin of SLE is unknown, several ideas propose a mix of genetic, environmental, and hormonal causes. It is also believed that your body's immune system attacks your organs, resulting in widespread inflammatory symptoms along with tissue damage.2

Overview of system-specific manifestations of SLE

SLE can affect almost every system in the body that's why it is a multisystem disease. However, the symptoms differ from one person to the other, and you might not have all the symptoms together expressed. Additionally, the symptoms are not permanent, i.e., they come and go (flare), which is usually called remission and relapse.3 Lupus symptoms include:

Musculoskeletal manifests of SLE and how to diagnose them

At some time throughout the disease, 80–90% of SLE patients experience musculoskeletal involvement, which can vary from moderate arthralgias to deforming arthritis.

Lupus arthritis

  • It is one of the most common symptoms of SLE, which nearly affects most of the body joints, especially the hands and knees.4
  • It is usually a symmetrical inflammatory polyarthritis that mostly affects the tiny joints in the hands, knees, and wrists.
  • Symptoms include symmetrical joint pain, stiffness, swelling, redness, limited mobility, and tenderness that may last from hours to even months. Joint deformity is not typical, but it is possible to occur, which is either erosive or non-erosive.
  • Lupus arthritis is an inflammatory process mediated by autoimmune antibodies towards your joints that, after a long time, if uncontrolled, will lead to joint damage.
  • Diagnosis is done by performing joint X-rays, which could be normal, magnetic resonance imaging (MRI) scan or synovial fluid analysis.
  • Many drugs such as non-steroidal inflammatory drugs, steroids or immunosuppressive medications work well to treat symptoms of lupus arthritis; nevertheless, long-term goals for lupus research involve finding treatments that are more specifically tailored to the joint symptoms and have fewer risks and side effects.

Tendon pathologies

  • Tendons are the fibrous tissue of the body that connects the muscles to the bones. Its importance lies in moving strong bones. Therefore, if it is affected by inflammation, you will not move your muscles properly, which will also give you pain. 
  • Tendon pathologies include tenosynovitis, bursitis, and tendon tear
  • Joint pain in lupus is rather due to tendonitis than arthritis or a combination of both.
  • Due to prolonged inflammation, it is difficult to control tendonitis while it is easier to control in the early stages.
  • Tenosynovitis is the affection of the sheath around the tendons. Usually, pain due to tenosynovitis occurs, for example, when bending your fingers. Trigger finger is a condition that means the inability to straighten your fingers.
  • Moreover, damage or rupture of the tendon occurs after a prolonged time of neglect to treatment, resulting in slipping of the tendon around the joint, causing the joint to become unstable or deformed.
  • Ultrasound is the best way to diagnose tendon problems.

Myalgia/Myositis

  • Myalgia, or muscular aches and pains, is frequently caused by lupus. Myositis, or inflammation of the muscles, is less frequent and typically affects the hips, thighs, shoulders, and upper arms. 
  • Muscle weakness is a common sign of myositis. It might be difficult to raise your arms or get out of a chair when you have lupus myositis. Certain lupus medications, such as steroids, can also weaken muscles. Usually, this adverse effect disappears after the medication, causing it to stop. Therefore, consult your physician before quitting any prescribed drugs.
  • Prednisone and other corticosteroids, often known as immunosuppressants, can slow down the immune system's attack on healthy tissue and reduce skin rashes. As your myositis therapy progresses, your doctor will likely order more blood tests to track your progress.5
  • For pain relief, you might also wish to consider using nonsteroidal anti-inflammatory medications like ibuprofen or aspirin.

Osteoporosis

  • If you are a lupus patient, then you might be susceptible to osteoporosis due to the inflammatory process of lupus and its treatment, such as prolonged steroid use.
  • Malnutrition of some lupus patients as an effect of their low mood can cause vitamin D deficiency that is needed in preventing osteoporosis.
  • Some other additional risk factors can contribute to increasing the risk of osteoporosis in lupus patients such as age, family history of osteoporosis, gender and ethnicity.
  • At first, osteoporosis may not present with any symptoms at all, but later, it can present with back or joint pain, postural changes, and shortening of height or stooping. The worst symptom that could happen in the late stages is an easy bone fracture, which mostly occurs by incidence and is diagnosed by x-ray.6
  • Lupus patients are screened regularly using bone mineral density (BMD) after 6 months of steroid therapy and repeated every 2 years.
  • Calcium supplements and vitamin D replacement are advised for lupus patients receiving corticosteroid therapy at a dose of 5 mg/day or higher of prednisone equivalent for some time longer than three months. For individuals with lupus nephritis, it is also advised to begin vitamin D supplementation at the time of first diagnosis.7 
  • Treatment options include calcium supplements, vitamin D, exercise, and healthy eating. Recommended medications include bisphosphonates, which aim at reducing bone turnover.

Fibromyalgia

  • Fibromyalgia is a disease that could occur separately or related to some diseases such as lupus (secondary fibromyalgia), therefore, due to overlapping symptoms, sometimes there is misinterpretation of both diseases and incorrect diagnosis could happen.8
  • It is most likely to occur in patients with SLE; rates have been recorded as high as 20%.
  •  Symptoms include tiredness all the time, feeling numb, headaches, stiff body, and pain in the joints and muscles.
  • Both lupus and fibromyalgia patients frequently cause discomfort in the joints and muscles. However, stiffness and oedema in the joints are common in lupus patients. Moving might be difficult for those who have this illness. On the other hand, the joints of those who have fibromyalgia don't swell and move normally.9
  • For a correct diagnosis to happen, a thorough history and physical examination should be done while investigations usually provide a definite diagnosis for lupus. 
  • Treatment of lupus patients with fibromyalgia includes steroid therapy or disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate if arthritis is proven to have occurred Otherwise, secondary fibromyalgia should be treated as primary fibromyalgia using pain relief medications and antidepressants.10

Summary

SLE manifests with diverse symptoms across multiple body systems, fluctuating in severity and exhibiting periods of remission and relapse. Musculoskeletal involvement, experienced by 80–90% of patients, ranges from mild joint pain to severe arthritis. Lupus arthritis affects various joints, causing pain, swelling, and potential damage. Tendon issues and muscle inflammation are common, while osteoporosis and fibromyalgia also affect SLE patients. Management involves medication, lifestyle adjustments, and regular monitoring to enhance quality of life.

References

  1. Barber MRW, Falasinnu T, Ramsey-Goldman R, Clarke AE. The global epidemiology of SLE: narrowing the knowledge gaps. Rheumatology (Oxford) [Internet]. 2023 Mar 29 [cited 2024 May 6];62(Suppl 1):i4–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050933/
  2. CDC. Centres for Disease Control and Prevention. 2023 [cited 2024 May 6]. Systemic lupus erythematosus (Sle). Available from: https://www.cdc.gov/lupus/facts/detailed.html
  3. COJOCARU M, COJOCARU IM, SILOSI I, VRABIE CD. Manifestations of systemic lupus erythematosus. Maedica (Bucur) [Internet]. 2011 Oct [cited 2024 May 9];6(4):330–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391953/
  4. Grossman JM. Lupus arthritis. Best Practice & Research Clinical Rheumatology [Internet]. 2009 Aug [cited 2024 May 9];23(4):495–506. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1521694209000448
  5. Treatment of myositis [Internet]. Johns Hopkins Myositis Center. [cited 2024 May 10]. Available from: https://www.hopkinsmyositis.org/unique/treatment-myositis/
  6. Jung JY, Choi ST, Park SH, Kwon SR, Kim HA, Kim SS, et al. Prevalence of osteoporosis in patients with systemic lupus erythematosus: A multicenter comparative study of the World Health Organization and fracture risk assessment tool criteria. Osteoporosis Sarcopenia [Internet]. 2020 Dec [cited 2024 May 10];6(4):173–8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783110/
  7. Humphrey MB, Russell L, Danila MI, Fink HA, Guyatt G, Cannon M, et al. 2022 american college of rheumatology guideline for the prevention and treatment of glucocorticoid‐induced osteoporosis. Arthritis & Rheumatology [Internet]. 2023 Dec [cited 2024 May 10];75(12):2088–102. Available from: https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.42646
  8. Gräfe A, Wollina U, Tebbe B, Sprott H, Uhlemann C, Hein G. Fibromyalgia in Lupus Erythematosus. Acta Derm Venereol [Internet]. 1999 Jan. 1 [cited 2024 May 12];79(1):62-4. Available from: https://medicaljournalssweden.se/actadv/article/view/14220
  9. Fibromyalgia, lupus or both? [Internet]. [cited 2024 May 12]. Available from: https://www.arthritis.org/diseases/more-about/fibromyalgia,-lupus,-or-both
  10. Wolfe F, Petri M, Alarcón GS, Goldman J, Chakravarty EF, Katz RS, et al. Fibromyalgia, systemic lupus erythematosus (Sle), and evaluation of SLE activity. J Rheumatol. 2009 Jan;36(1):82–8.
Share

Rana Ibrahim

Masters of Critical care - Faculty of Medicine, Alexandria University, Egypt

Rana is a qualified medical professional specialising in critical care medicine. She has several years of expertise in the profession and a consistent commitment to clinical excellence and patient care. She has lately been involved in medical writing, driven by her recently discovered passion, using her knowledge and perceptions to teach and educate members of the medical community as well as the society as a whole.

arrow-right